199 related articles for article (PubMed ID: 14675282)
1. Histological characterization of regression in acquired immunodeficiency syndrome-related Kaposi's sarcoma.
Pantanowitz L; Dezube BJ; Pinkus GS; Tahan SR
J Cutan Pathol; 2004 Jan; 31(1):26-34. PubMed ID: 14675282
[TBL] [Abstract][Full Text] [Related]
2. The spindle-shaped cells in cutaneous Kaposi's sarcoma. Histologic simulators include factor XIIIa dermal dendrocytes.
Nickoloff BJ; Griffiths CE
Am J Pathol; 1989 Nov; 135(5):793-800. PubMed ID: 2573283
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma.
Gill PS; Tulpule A; Espina BM; Cabriales S; Bresnahan J; Ilaw M; Louie S; Gustafson NF; Brown MA; Orcutt C; Winograd B; Scadden DT
J Clin Oncol; 1999 Jun; 17(6):1876-83. PubMed ID: 10561228
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations.
Stebbing J; Wildfire A; Portsmouth S; Powles T; Thirlwell C; Hewitt P; Nelson M; Patterson S; Mandalia S; Gotch F; Gazzard BG; Bower M
Ann Oncol; 2003 Nov; 14(11):1660-6. PubMed ID: 14581275
[TBL] [Abstract][Full Text] [Related]
5. Histology of early lesions of AIDS-associated Kaposi's sarcoma.
Niedt GW; Myskowski PL; Urmacher C; Niedzwiecki D; Chapman D; Safai B
Mod Pathol; 1990 Jan; 3(1):64-70. PubMed ID: 2308922
[TBL] [Abstract][Full Text] [Related]
6. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome.
Cattelan AM; Calabrò ML; Gasperini P; Aversa SM; Zanchetta M; Meneghetti F; De Rossi A; Chieco-Bianchi L
J Natl Cancer Inst Monogr; 2001; (28):44-9. PubMed ID: 11158206
[TBL] [Abstract][Full Text] [Related]
7. Angioproliferative changes in clinically noninvolved, perilesional skin in AIDS-associated Kaposi's sarcoma.
Ruszczak Z; Mayer da Silva A; Orfanos CE
Dermatologica; 1987; 175(6):270-9. PubMed ID: 3691903
[TBL] [Abstract][Full Text] [Related]
8. Immunihistochemical detection of Bcl-2 in AIDS-associated and classical Kaposi's sarcoma.
Morris CB; Gendelman R; Marrogi AJ; Lu M; Lockyer JM; Alperin-Lea W; Ensoli B
Am J Pathol; 1996 Apr; 148(4):1055-63. PubMed ID: 8644847
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of spindle cells in Kaposi's sarcoma: comparison of cells in lesions and in culture.
Kaaya EE; Parravicini C; Ordonez C; Gendelman R; Berti E; Gallo RC; Biberfeld P
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):295-305. PubMed ID: 7552491
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of paclitaxel activity in Kaposi's sarcoma.
Sgadari C; Toschi E; Palladino C; Barillari G; Carlei D; Cereseto A; Ciccolella C; Yarchoan R; Monini P; Stürzl M; Ensoli B
J Immunol; 2000 Jul; 165(1):509-17. PubMed ID: 10861090
[TBL] [Abstract][Full Text] [Related]
11. Spindle cells from AIDS-associated Kaposi's sarcoma lesions express telomerase activity that is enhanced by Kaposi's sarcoma progression factors.
Barillari G; Franzese O; Comandini A; Bonmassar E; Ensoli B
Oncol Rep; 2010 Jul; 24(1):219-23. PubMed ID: 20514465
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases in the progression and regression of Kaposi's sarcoma.
Pantanowitz L; Dezube BJ; Hernandez-Barrantes S; Tahan SR; Dabbous MK
J Cutan Pathol; 2006 Dec; 33(12):793-8. PubMed ID: 17177939
[TBL] [Abstract][Full Text] [Related]
13. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients.
Dictor M; Rambech E; Way D; Witte M; Bendsöe N
Am J Pathol; 1996 Jun; 148(6):2009-16. PubMed ID: 8669485
[TBL] [Abstract][Full Text] [Related]
14. Unique histologic variants of cutaneous Kaposi sarcoma.
OʼDonnell PJ; Pantanowitz L; Grayson W
Am J Dermatopathol; 2010 May; 32(3):244-250. PubMed ID: 20075709
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel for AIDS-associated Kaposi's sarcoma.
Dhillon T; Stebbing J; Bower M
Expert Rev Anticancer Ther; 2005 Apr; 5(2):215-9. PubMed ID: 15877519
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy for AIDS-related and endemic African Kaposi's sarcoma in southern Africa.
Stein ME; Lachter J; Spencer D; Bezwoda WR
Int J Dermatol; 1995 Oct; 34(10):729-32. PubMed ID: 8537166
[TBL] [Abstract][Full Text] [Related]
17. Non-pigmented oral kaposi's sarcoma (AIDS). Report of two cases.
Reichart PA; Schiødt M
Int J Oral Maxillofac Surg; 1989 Aug; 18(4):197-9. PubMed ID: 2507665
[TBL] [Abstract][Full Text] [Related]
18. Cryotherapy for cutaneous Kaposi's sarcoma (KS) associated with acquired immune deficiency syndrome (AIDS): a phase II trial.
Tappero JW; Berger TG; Kaplan LD; Volberding PA; Kahn JO
J Acquir Immune Defic Syndr (1988); 1991; 4(9):839-46. PubMed ID: 1895204
[TBL] [Abstract][Full Text] [Related]
19. Treatment with taxanes of refractory or life-threatening Kaposi sarcoma not associated with human immunodeficiency virus infection.
Fardet L; Stoebner PE; Bachelez H; Descamps V; Kerob D; Meunier L; Dandurand M; Morel P; Lebbe C
Cancer; 2006 Apr; 106(8):1785-9. PubMed ID: 16534786
[TBL] [Abstract][Full Text] [Related]
20. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells.
Fiorelli V; Gendelman R; Samaniego F; Markham PD; Ensoli B
J Clin Invest; 1995 Apr; 95(4):1723-34. PubMed ID: 7535796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
